Akcea Therapeutics Inc., is a North American biopharmaceutical company. The Company develops and commercializes drugs for the treatment of patients with cardiometabolic diseases caused by lipid disorders. Our priority is to drive clinical program execution, understand patient and physician needs, prepare the market, create market access, and commercialize our products on a global basis.
We don't have any social media account of this company
TEGSEDI™ (inotersen solution for subcutaneous injection) is indicated for the treatment of
stage 1 or stage 2 polyneuropathy in adult patients with hereditary transthyretin amyloidosis
(hATTR)
Do you own a business?
We help you grow it
Get more clients, visibility and branding.
Let us help you achieve your targets and improve your business.
Reviews of Akcea Therapeutics Inc. (0)